Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00CCI
|
|||
| Former ID |
DCL000338
|
|||
| Drug Name |
Benoxaprofen
|
|||
| Synonyms |
Benoxaprofene; Benoxaprofeno; Benoxaprofenum; Coxigon; Inflamid; Opren; Oraflex; Uniprofen; LRCL3794; Lilly 90459; Benoxaprofene [INN-French]; Benoxaprofeno [INN-Spanish]; Benoxaprofenum [INN-Latin]; Dl-Benoxaprofen; Oraflex (TN); Benoxaprofen (USAN/INN); Benoxaprofen [USAN:INN:BAN]; (+-)-2-(p-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid; (-)-2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid; (-)-Benoxaprofen; (1)-2-(4-Chlorophenyl)benzoxazole-5-propionic acid; 2-(2-(4-Chlorophenyl)-1,3-benzoxazol-5-yl)propanoic acid; 2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid; 2-(p-Chlorophenyl)-.alpha.-methyl-5-benzoxazoleacetic acid; 2-[2-(4-Chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Withdrawn from market | [1] | |
| Company |
Eli Lilly
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H12ClNO3
|
|||
| Canonical SMILES |
CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O
|
|||
| InChI |
1S/C16H12ClNO3/c1-9(16(19)20)11-4-7-14-13(8-11)18-15(21-14)10-2-5-12(17)6-3-10/h2-9H,1H3,(H,19,20)
|
|||
| InChIKey |
MITFXPHMIHQXPI-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 51234-28-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
147908, 224775, 5305710, 8176323, 10524732, 12015308, 15023419, 17397235, 34705785, 46508496, 48415610, 49892019, 50154871, 57288750, 57312361, 103367920, 104333099, 117542968, 126666093, 126687083, 128601792, 134223756, 134338992, 135000902, 135127612, 137006826, 143201304, 160967788, 162635350, 164347369, 179150523, 223671949, 223678444, 225249486, 226412765, 249810602, 250102997, 251892107
|
|||
| ChEBI ID |
CHEBI:76114
|
|||
| SuperDrug ATC ID |
M01AE06
|
|||
| SuperDrug CAS ID |
cas=051234287
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Benoxaprofen: side-effect profile in 300 patients. Br Med J (Clin Res Ed). 1982 May 8;284(6326):1365-8. | |||
| REF 2 | Inhibition of lyso-PAF: acetyl-CoA acetyltransferase by salicylates and other compounds. Prostaglandins. 1988 Jun;35(6):939-44. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.